SecurityCBOE / CBOE Holdings, Inc. (12503M108)
IndustrySecurity And Commodity Brokers, Dealers, Exchanges, And Services
Common Stock Shares Outstanding112,741,217 shares (as of 2017-12-31)
Total Insiders30
Total Directors17
Total Officers14

Stock Insider Trading (from SEC Form 4)

CBOE Holdings, Inc. insider trades are listed in the following table, followed by a table containing the full transaction history. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

CBOE / CBOE Holdings, Inc. insiders include Schell Brian N, O'Connell Gerald T, Deters John, Froetscher Janet P, Lowenthal Andrew, and RATTERMAN JOSEPH P, Tilly Edward T, MARTIN R EDEN, REYNOLDS DAVID S, SKINNER SAMUEL K, Goodman Jill R, Sunshine Eugene S, Fitzpatrick Edward J., Stone Carole E, PALMORE RODERICK A, Hemsley Mark S, Harkins Bryan PHILLIPS SUSAN M, Sexton John P, Mitchell Christopher, English Frank E. Jr., Moffic-Silver Joanne, BRODSKY WILLIAM J, BORIS JAMES R, Dean Alan J, Isaacson Christopher A, Richter Michael L, CONCANNON CHRISTOPHER R, Provost Edward L, Farrow William M III, .

Insider Roster

Insider Dir Off 10% Shares Owned
Lowenthal Andrew EVP, Global Derivatives
X 12,657
Sexton John P EVP, GC and Corp Sec
X 29,826
Deters John EVP, Corporate Strategy
X 6,242
Harkins Bryan EVP, Equities and FX
X 83,878
Hemsley Mark S Executive VP, President Europe
X 97,654
Isaacson Christopher A Executive VP, CIO
X 77,500
Schell Brian N Executive VP, CFO & Treasurer
X 55,541
CONCANNON CHRISTOPHER R President and COO
X 142,526
Moffic-Silver Joanne Former EVP, GC, and Corp Sec
X 82,561
Tilly Edward T Chairman and CEO, Director
X X 102,000
REYNOLDS DAVID S Chief Accounting Officer
X 5,376
Dean Alan J Former EVP, CFO & Treasurer
X 75,052
BORIS JAMES R Director
X 10,161
English Frank E. Jr. Director
X 4,214
RATTERMAN JOSEPH P Director
X 32,513
Mitchell Christopher Director
X 0
Stone Carole E Director
X 14,241
Fitzpatrick Edward J. Director
X 7,429
Farrow William M III Director
X 2,766
PALMORE RODERICK A Director
X 17,761
Goodman Jill R Director
X 10,214
Froetscher Janet P Director
X 18,061
Sunshine Eugene S Director
X 18,061
SKINNER SAMUEL K Director
X 18,061
Richter Michael L Director
X 22,181
O'Connell Gerald T Former Executive VP and CIO
X
Provost Edward L Former President & COO
X
BRODSKY WILLIAM J Director
X
PHILLIPS SUSAN M Director
X
MARTIN R EDEN Director
X

Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b-5 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Form Insider Code 10b-5 Direct Share
Price
Shares
Changed
Remaining
Shares
Post Value
2018-03-16 4 Lowenthal Andrew L D 119.73 28 12,657
2018-02-28 4 Moffic-Silver Joanne F D 112.01 -181 82,561
2018-02-28 4 Moffic-Silver Joanne M D 408 82,742
2018-02-28 4 Moffic-Silver Joanne F D 112.01 -1,801 82,334
2018-02-28 4 Moffic-Silver Joanne M D 4,064 84,135
2018-02-28 4 Moffic-Silver Joanne F D 112.01 -1,057 80,071
2018-02-28 4 Moffic-Silver Joanne M D 2,384 81,128
2018-02-28 4 Moffic-Silver Joanne F D 112.01 -586 78,744
2018-02-28 4 Moffic-Silver Joanne M D 1,322 79,330
2018-02-28 4 CONCANNON CHRISTOPHER R F D 112.01 -2,031 142,526
2018-02-28 4 CONCANNON CHRISTOPHER R M D 112.01 4,146 144,557
2018-02-28 4 Schell Brian N F D 112.01 -919 55,541
2018-02-28 4 Schell Brian N M D 112.01 2,073 56,460
2018-02-28 4 Isaacson Christopher A F D 112.01 -460 77,500
2018-02-28 4 Isaacson Christopher A M D 112.01 1,036 77,960
2018-02-28 4 Hemsley Mark S F D 112.01 -581 97,654
2018-02-28 4 Hemsley Mark S M D 112.01 1,235 98,235
2018-02-19 4 REYNOLDS DAVID S F D 111.45 -218 5,376
2018-02-19 4 REYNOLDS DAVID S F D 111.45 -218 5,376
2018-02-19 4 REYNOLDS DAVID S F D 111.45 -278 5,812
2018-02-19 4 REYNOLDS DAVID S F D 111.45 -309 6,090
2018-02-19 4 REYNOLDS DAVID S M D 111.45 741 6,399
2018-02-19 4 REYNOLDS DAVID S M D 111.45 741 6,399
2018-02-19 4 REYNOLDS DAVID S M D 111.45 965 4,917
2018-02-19 4 REYNOLDS DAVID S M D 111.45 904 3,952
2018-02-19 4 Moffic-Silver Joanne F D 111.45 -900 78,008
2018-02-19 4 Moffic-Silver Joanne F D 111.45 -529 78,908
2018-02-19 4 Moffic-Silver Joanne F D 111.45 -466 79,437
2018-02-19 4 Moffic-Silver Joanne F D 111.45 -387 79,903
2018-02-19 4 Moffic-Silver Joanne M D 111.45 2,031 80,290
2018-02-19 4 Moffic-Silver Joanne M D 111.45 1,192 78,259
2018-02-19 4 Moffic-Silver Joanne M D 111.45 1,322 77,067
2018-02-19 4 Moffic-Silver Joanne M D 111.45 1,319 75,745
2018-02-19 4 Tilly Edward T F D 111.45 -4,592 102,000
2018-02-19 4 Tilly Edward T F D 111.45 -2,756 106,592
2018-02-19 4 Tilly Edward T F D 111.45 -2,987 109,348
2018-02-19 4 Tilly Edward T F D 111.45 -2,384 112,335
2018-02-19 4 Tilly Edward T M D 111.45 10,365 114,719
2018-02-19 4 Tilly Edward T M D 111.45 6,219 104,354
2018-02-19 4 Tilly Edward T M D 111.45 6,742 98,135
2018-02-19 4 Tilly Edward T M D 111.45 5,380 91,393
2018-02-14 4 Tilly Edward T F D 115.0 -10,696 86,013
2018-02-14 4 Tilly Edward T A D 27,098 96,709
2018-02-14 4 Moffic-Silver Joanne F D 115 -1,977 74,427
2018-02-14 4 Moffic-Silver Joanne A D 6,642 76,404
2018-01-13 4 CONCANNON CHRISTOPHER R F D 131.51 -854 140,411
2018-01-13 4 Hemsley Mark S F D 131.51 -366 97,000
2018-01-13 4 Hemsley Mark S F D 131.51 -3,806 97,366
2018-01-13 4 Isaacson Christopher A F D 131.51 -493 76,924
2018-01-13 4 Isaacson Christopher A F D 131.51 -4,155 77,417
2018-01-13 4 Schell Brian N F D 131.51 -591 54,387
2018-01-13 4 Schell Brian N F D 131.51 -3,719 54,978
2017-12-31 4 Dean Alan J F D 124.59 -4,901 75,052
2017-12-31 4 Dean Alan J M D 10,448 79,953
2017-12-31 4 Dean Alan J F D 124.59 -2,245 69,505
2017-12-31 4 Dean Alan J M D 5,224 71,750
2017-12-31 4 Dean Alan J F D 124.59 -1,464 66,526
2017-12-31 4 Dean Alan J M D 4,532 67,990
2017-12-31 4 Dean Alan J F D 124.59 -724 63,458
2017-12-31 4 Dean Alan J M D 2,088 64,182
2017-12-15 4 CONCANNON CHRISTOPHER R F D 126.37 -5,414 141,265
2017-12-15 4 Hemsley Mark S F D 126.37 -930 101,172
2017-12-15 4 Isaacson Christopher A F D 126.37 -495 81,572
2017-12-05 4 Isaacson Christopher A G D -6,000 82,067
2017-12-12 4 Tilly Edward T G D -1,000 69,611
2017-12-11 4 Tilly Edward T S X D 126.28 -5,000 70,611 8,916,757
2017-12-07 4 BORIS JAMES R G D -3,300 10,161
2017-12-05 4 RATTERMAN JOSEPH P G I -24,400 32,513
2017-12-06 4 English Frank E. Jr. S D 123.80 -300 4,214 521,693
2017-12-01 4 Hemsley Mark S F D 124.25 -2,709 102,102
2017-12-01 4 Hemsley Mark S F D 124.25 -3,268 104,811
2017-12-01 4 Hemsley Mark S F D 124.25 -3,352 108,079
2017-12-01 4 CONCANNON CHRISTOPHER R F D 124.25 -9,601 146,679
2017-12-01 4 CONCANNON CHRISTOPHER R F D 124.25 -8,184 156,280
2017-12-01 4 Isaacson Christopher A S X D 124.42 -7,019 88,067 10,957,296
2017-12-01 4 Isaacson Christopher A M X D 12.63 7,019 95,086
2017-12-01 4 Isaacson Christopher A F D 124.25 -1,118 88,067
2017-12-01 4 Isaacson Christopher A F D 124.25 -1,044 89,185
2017-12-01 4 Isaacson Christopher A F D 124.25 -648 90,229
2017-11-29 4 Mitchell Christopher See Footnotes S I 120.8878 -670 0
2017-11-28 4 Mitchell Christopher J D 7,353 8,808
2017-11-28 4 Mitchell Christopher See Footnotes J I -239,300 0
2017-10-12 4 REYNOLDS DAVID S S X D 108.82 -3,000 3,048 331,683
2017-10-12 4 REYNOLDS DAVID S S X D 110.00 -1,000 6,048 665,280
2017-09-11 4 Tilly Edward T S X D 105.52 -5,000 75,611 7,978,473
2017-09-01 4 Isaacson Christopher A S X D 100.61 -7,020 90,877 9,143,135
2017-09-01 4 Isaacson Christopher A M X D 12.63 7,020 97,897
2017-08-28 4 RATTERMAN JOSEPH P G I -11,000 55,458
2017-03-20 4 RATTERMAN JOSEPH P G I 10,720 66,458
2017-03-20 4 RATTERMAN JOSEPH P G D -10,720 1,455
2017-08-25 4 English Frank E. Jr. S D 99.59 -700 4,514 449,549
2017-08-15 4 Mitchell Christopher See Footnotes S I 97.6496 -200,000 241,425 23,575,055
2017-08-14 4 Stone Carole E S D 97.14 -1,520 14,241 1,383,371
2017-06-12 4 Isaacson Christopher A S X D 89.21 -7,316 90,877 8,107,137
2017-06-09 4 Mitchell Christopher See Footnotes S I 89.3505 -69,589 441,425 39,441,544
2017-06-08 4 Mitchell Christopher See Footnotes S I 89.0925 -155,411 511,014 45,527,515
2017-06-05 4 Tilly Edward T S X D 86.85 -5,000 80,611 7,001,065
2017-05-18 4 Richter Michael L A D 1,185 22,181
2017-05-18 4 SKINNER SAMUEL K A D 1,185 18,061
2017-05-18 4 Stone Carole E A D 1,185 15,761
2017-05-18 4 Sunshine Eugene S A D 1,185 18,061
2017-05-18 4 Froetscher Janet P A D 1,185 18,061
2017-05-18 4 Goodman Jill R A D 1,185 10,214
2017-05-18 4 Mitchell Christopher A D 1,185 666,425
2017-05-18 4 PALMORE RODERICK A A D 1,185 17,761
2017-05-18 4 RATTERMAN JOSEPH P A D 1,185 67,913
2017-05-18 4 BORIS JAMES R A D 1,185 13,461
2017-05-18 4 English Frank E. Jr. A D 1,185 5,214
2017-05-18 4 Farrow William M III A D 1,185 2,766
2017-05-18 4 Fitzpatrick Edward J. A D 1,185 7,429
2017-05-12 4 English Frank E. Jr. S D 84.33 -400 4,029 339,766
2017-05-12 4 RATTERMAN JOSEPH P S I 84.06 -175,955 66,728 5,609,156
2017-03-27 4 Tilly Edward T S X D 78.61 -5,000 85,611 6,729,881
2017-03-07 4 Mitchell Christopher See Footnotes S I 78.1597 -47,816 665,240 51,994,959
2017-03-06 4 Mitchell Christopher See Footnotes S I 78.1998 -171,184 713,056 55,760,837
2017-03-03 4 Mitchell Christopher See Footnotes S I 78.5638 -1,000 884,240 69,469,255
2017-03-03 4 Mitchell Christopher See Footnotes S I 78.3206 -250,000 885,240 69,332,528
2017-03-03 4 English Frank E. Jr. S D 78.62 -1,300 4,429 348,208
2017-02-28 4 CONCANNON CHRISTOPHER R A D 164,464 164,464
2017-02-28 4 Isaacson Christopher A A D 98,191 98,191
2017-02-28 4 Hemsley Mark S A D 111,431 111,431
2017-02-28 4 Mitchell Christopher A D 270 1,135,240
2017-02-28 4 Mitchell Christopher See footnotes A I 1,134,970 1,134,970
2017-02-28 4 Richter Michael L A D 270 20,997
2017-02-28 4 Richter Michael L A D 20,727 20,727
2017-02-28 4 RATTERMAN JOSEPH P A D 270 242,683
2017-02-28 4 RATTERMAN JOSEPH P A I 231,693 242,413
2017-02-28 4 RATTERMAN JOSEPH P A D 10,720 10,720
2017-02-28 4 Provost Edward L F D 78.05 -4,477 91,747
2017-02-28 4 Provost Edward L M D 9,795 96,224
2017-02-28 4 Provost Edward L F D 78.05 -3,883 86,429
2017-02-28 4 Provost Edward L M D 8,496 90,312
2017-02-28 4 Provost Edward L F D 78.05 -1,630 81,816
2017-02-28 4 Provost Edward L M D 3,565 83,446
2017-02-28 4 O'Connell Gerald T F D 78.05 -1,933 71,893
2017-02-28 4 O'Connell Gerald T M D 4,229 73,826
2017-02-28 4 O'Connell Gerald T F D 78.05 -1,677 69,597
2017-02-28 4 O'Connell Gerald T M D 3,668 71,274
2017-02-28 4 O'Connell Gerald T F D 78.05 -837 67,606
2017-02-28 4 O'Connell Gerald T M D 1,830 68,443
2017-02-19 4 REYNOLDS DAVID S F D 80.94 -299 7,048
2017-02-19 4 REYNOLDS DAVID S F D 80.94 -282 7,347
2017-02-19 4 REYNOLDS DAVID S F D 80.94 -357 7,629
2017-02-19 4 REYNOLDS DAVID S M D 80.94 964 7,986
2017-02-19 4 REYNOLDS DAVID S M D 80.94 904 7,022
2017-02-19 4 REYNOLDS DAVID S M D 80.94 979 6,118
2017-02-19 4 Tilly Edward T F D 80.94 -3,082 90,690
2017-02-19 4 Tilly Edward T F D 80.94 -2,459 93,772
2017-02-19 4 Tilly Edward T F D 80.94 -2,456 96,231
2017-02-19 4 Tilly Edward T M D 80.94 6,742 98,687
2017-02-19 4 Tilly Edward T M D 80.94 5,380 91,945
2017-02-19 4 Tilly Edward T M D 80.94 5,374 86,565
2017-02-19 4 Dean Alan J F D 80.94 -1,036 62,150
2017-02-19 4 Dean Alan J F D 80.94 -816 63,186
2017-02-19 4 Dean Alan J F D 80.94 -727 64,002
2017-02-19 4 Dean Alan J M D 80.94 2,265 64,729
2017-02-19 4 Dean Alan J M D 80.94 2,088 62,464
2017-02-19 4 Dean Alan J M D 80.94 2,337 60,376
2017-02-19 4 Provost Edward L F D 80.94 -1,941 79,959
2017-02-19 4 Provost Edward L F D 80.94 -1,629 81,900
2017-02-19 4 Provost Edward L F D 80.94 -1,520 83,529
2017-02-19 4 Provost Edward L M D 80.94 4,247 85,049
2017-02-19 4 Provost Edward L M D 80.94 3,564 80,802
2017-02-19 4 Provost Edward L M D 80.94 3,324 77,238
2017-02-19 4 O'Connell Gerald T F D 80.94 -761 66,663
2017-02-19 4 O'Connell Gerald T F D 80.94 -569 67,424
2017-02-19 4 O'Connell Gerald T F D 80.94 -637 67,993
2017-02-19 4 O'Connell Gerald T M D 80.94 1,834 68,630
2017-02-19 4 O'Connell Gerald T M D 80.94 1,829 66,796
2017-02-19 4 O'Connell Gerald T M D 80.94 2,048 64,967
2017-02-19 4 Moffic-Silver Joanne F D 80.94 -411 69,761
2017-02-19 4 Moffic-Silver Joanne F D 80.94 -410 70,172
2017-02-19 4 Moffic-Silver Joanne F D 80.94 -460 70,582
2017-02-19 4 Moffic-Silver Joanne M D 80.94 1,321 71,042
2017-02-19 4 Moffic-Silver Joanne M D 80.94 1,318 69,721
2017-02-19 4 Moffic-Silver Joanne M D 80.94 1,476 68,403
2017-02-16 4 Provost Edward L F D 80.16 -4,334 73,914
2017-02-15 4 Provost Edward L A D 13,583 78,248
2017-02-16 4 O'Connell Gerald T F D 80.16 -2,641 62,919
2017-02-15 4 O'Connell Gerald T A D 8,371 65,560
2017-02-16 4 Moffic-Silver Joanne F D 80.16 -1,914 66,927
2017-02-15 4 Moffic-Silver Joanne A D 6,033 68,841
2017-02-16 4 Dean Alan J F D 80.16 -3,007 58,039
2017-02-15 4 Dean Alan J A D 9,551 61,046
2017-02-16 4 Tilly Edward T F D 80.16 -8,133 81,191
2017-02-15 4 Tilly Edward T A D 21,963 89,324
2016-12-15 4 Provost Edward L G D -2,622 64,665
2016-12-12 4 Tilly Edward T S D 76.79 -6,250 67,361 5,172,651
2016-11-14 4 BRODSKY WILLIAM J G D -2,500 213,735
2016-11-11 4 BRODSKY WILLIAM J G D -2,500 216,235
2016-09-12 4 Tilly Edward T S D 67.86 -6,250 73,611 4,995,242
2016-06-14 4 O'Connell Gerald T S D 65.00 -14,909 57,189 3,717,285
2016-06-13 4 Tilly Edward T S D 64.46 -6,250 79,861 5,147,840
2016-06-06 4 BRODSKY WILLIAM J S D 62.82 -5,000 218,735 13,740,933
2016-05-19 4 Farrow William M III A D 1,581 1,581
2016-05-19 4 BORIS JAMES R A D 1,581 12,276
2016-05-19 4 BRODSKY WILLIAM J A D 1,581 223,735
2016-05-19 4 MARTIN R EDEN A D 1,581 16,876
2016-05-19 4 PALMORE RODERICK A A D 1,581 16,576
2016-05-19 4 PHILLIPS SUSAN M A D 1,581 16,876
2016-05-19 4 Sunshine Eugene S A D 1,581 16,876
2016-05-19 4 SKINNER SAMUEL K A D 1,581 16,876
2016-05-19 4 Stone Carole E A D 1,581 14,576
2016-05-19 4 Fitzpatrick Edward J. A D 1,581 6,244
2016-05-19 4 English Frank E. Jr. A D 1,581 5,729
2016-05-19 4 Froetscher Janet P A D 1,581 16,876
2016-05-19 4 Goodman Jill R A D 1,581 9,029
2016-05-18 4 BRODSKY WILLIAM J S D 62.71 -5,000 222,154 13,931,277
2016-04-18 4 BRODSKY WILLIAM J S D 63.87 -5,000 227,154 14,508,326
2016-04-12 4 REYNOLDS DAVID S S D 63.93 -2,500 5,139 328,536
2016-04-07 4 REYNOLDS DAVID S S D 65.64 -300 15,575 1,022,343
2016-04-05 4 REYNOLDS DAVID S S D 65.89 -1,000 15,575 1,026,237
2016-04-01 4 Dean Alan J S D 65.12 -3,047 51,495 3,353,354
2016-03-28 4 Provost Edward L S D 65.00 -5,047 67,287 4,373,655
2016-03-09 4 Tilly Edward T S D 65.39 -6,250 86,111 5,630,798
2016-02-19 4 REYNOLDS DAVID S M D 62.74 979 36,287
2016-02-19 4 REYNOLDS DAVID S M D 62.74 904 36,287
2016-02-19 4 REYNOLDS DAVID S F D 62.74 -296 36,287
2016-02-19 4 REYNOLDS DAVID S F D 62.74 -281 36,287
2016-02-19 4 O'Connell Gerald T M D 62.74 2,048 289,544
2016-02-19 4 O'Connell Gerald T M D 62.74 1,829 289,544
2016-02-19 4 O'Connell Gerald T F D 62.74 -637 289,544
2016-02-19 4 O'Connell Gerald T F D 62.74 -569 289,544
2016-02-19 4 Provost Edward L M D 62.74 3,323 291,167
2016-02-19 4 Provost Edward L M D 62.74 3,564 291,167
2016-02-19 4 Provost Edward L F D 62.74 -1,034 291,167
2016-02-19 4 Provost Edward L F D 62.74 -1,109 291,167
2016-02-19 4 Moffic-Silver Joanne M D 62.74 1,476 252,064
2016-02-19 4 Moffic-Silver Joanne M D 62.74 1,318 252,064
2016-02-19 4 Moffic-Silver Joanne F D 62.74 -460 252,064
2016-02-19 4 Moffic-Silver Joanne F D 62.74 -410 252,064
2016-02-19 4 Dean Alan J M D 62.74 2,337 219,485
2016-02-19 4 Dean Alan J M D 62.74 2,087 219,485
2016-02-19 4 Dean Alan J F D 62.74 -727 219,485
2016-02-19 4 Dean Alan J F D 62.74 -650 219,485
2016-02-19 4 Tilly Edward T M D 62.74 5,374 375,685
2016-02-19 4 Tilly Edward T M D 62.74 5,380 375,685
2016-02-19 4 Tilly Edward T F D 62.74 -2,122 375,685
2016-02-19 4 Tilly Edward T F D 62.74 -2,459 375,685
2016-02-05 4 REYNOLDS DAVID S F D 60.65 -574 7,633
2016-02-05 4 O'Connell Gerald T F D 60.65 -2,121 69,427
2016-02-05 4 Provost Edward L F D 60.65 -2,348 67,590
2016-02-05 4 Moffic-Silver Joanne F D 60.65 -1,546 60,884
2016-02-08 4 Dean Alan J S D 58.57 -7,500 110,490 6,471,399
2016-02-05 4 Dean Alan J F D 60.65 -2,326 110,490
2016-02-05 4 Tilly Edward T F D 60.65 -4,411 86,188
2015-12-21 4 Tilly Edward T S D 65.11 -6,250 90,599 5,898,901
2015-12-02 4 BRODSKY WILLIAM J S D 70.13 -4,300 250,154 17,543,300
2015-12-01 4 BRODSKY WILLIAM J G D -3,600 254,454
2015-11-17 4 BRODSKY WILLIAM J G D -8,100 258,054
2015-08-07 4 BRODSKY WILLIAM J G D -18,000 266,154
2015-11-03 4 English Frank E. Jr. S D 68.77 -1,800 4,148 285,258
2015-10-15 4 Provost Edward L S D 66.10 -5,000 70,669 4,671,221
2015-10-08 4 Dean Alan J S D 65.01 -6,586 61,321 3,986,478
2015-09-15 4 Tilly Edward T S D 66.02 -6,250 96,849 6,393,971
2015-07-15 4 Provost Edward L S D 60.64 -5,000 75,669 4,588,568
2015-07-13 4 O'Connell Gerald T S D 62.00 -9,909 71,548 4,435,976
2015-07-06 4 Provost Edward L S D 60.02 -5,000 80,669 4,841,753
2015-06-16 4 Tilly Edward T S D 59.16 -6,250 103,099 6,099,337
2015-05-21 4 BORIS JAMES R A D 1,292 15,295
2015-05-21 4 BRODSKY WILLIAM J A D 1,292 284,154
2015-05-21 4 MARTIN R EDEN A D 1,292 15,295
2015-05-21 4 PALMORE RODERICK A A D 1,292 14,995
2015-05-21 4 PHILLIPS SUSAN M A D 1,292 15,295
2015-05-21 4 SKINNER SAMUEL K A D 1,292 15,295
2015-05-21 4 Sunshine Eugene S A D 1,292 15,295
2015-05-21 4 Stone Carole E A D 1,292 12,995
2015-05-21 4 Fitzpatrick Edward J. A D 1,292 4,663
2015-05-21 4 English Frank E. Jr. A D 1,292 5,948
2015-05-21 4 Froetscher Janet P A D 1,292 15,295
2015-05-21 4 Goodman Jill R A D 1,292 7,448
2015-03-23 4 Tilly Edward T S D 59.39 -6,250 109,349 6,494,237
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...